Noninfectious liver injury, including the effects of drugs and diet, is a major cause of liver diseases worldwide. The innate inflammatory response to hepatocyte death plays a crucial role in the outcome of liver injury. Mannan-binding lectin (MBL) is a pattern recognition molecule of the innate immune system, which is primarily produced by liver. MBL deficiency occurs with high frequency in the population and is reported associated with predisposition to infectious diseases. We here observed that genetic MBL ablation strongly sensitizes mice to sterile liver injury induced by carbon tetrachloride (CCl 4 ). Aggravated liver damage was shown in CCl 4 -administrated MBL −/− mice, as evidenced by severe hepatocyte death, elevated serum alanine aminotransferase and lactate dehydrogenase activity, and enhanced production of inflammatory cytokines. Mechanistic studies established that MBL deficiency caused increased chemokine CXCL2 production from liver macrophages upon CCl 4 stimulation, thereby promoting the hepatic recruitment of neutrophils and subsequent liver damage. Furthermore, MBL-mediated protection from CCl 4 -induced liver injury was validated by administration of an MBL-expressing liver-specific adenoassociated virus, which effectively ameliorated the hepatic damage in CCl4-treated MBL -/-mice.
INTRODUCTION
Liver diseases are associated with significant mortality and represent one of the major world public health problems. In the liver, sterile inflammation is particularly important because it is a significant component of the pathology of a wide range of diseases, such as alcoholic steatohepatitis, nonalcoholic steatohepatitis, drug-induced liver injury, and ischemia/reperfusion. 1 The most well-known trigger for sterile inflammation is necrotic cell death accompanied with the production of a mass of damage-associated molecular patterns (DAMPs), which are released into the extracellular space under conditions of activation, cellular stress, or tissue damage. 1, 2 In response to liver injury and the release of DAMPs, both macrophages and neutrophils will rapidly flux into the sites of hepatic sterile inflammation. 3 Once the cells reach the liver, they can cause mild-to-severe tissue damage and consequent liver failure. 3, 4 It is therefore of critical importance to broaden our understanding of the molecular mechanisms that control the innate immune cells trafficking during sterile inflammation.
Mannan-binding lectin (MBL, also called mannose-binding lectin)
is a prototypic pattern recognition molecule of the innate immune system, mainly produced by hepatocytes. 5, 6 MBL is able to differentiate between the carbohydrates found on self-glycoproteins and the carbohydrate patterns found on infectious non-self surfaces and initiates the complement cascade through the lectin pathway. 5, 7 Emerging evidence suggested that MBL deficiency is associated with susceptibility to several liver diseases, including liver fibrosis, 8 viral hepatitis B, 9 ,10 viral hepatitis C, 8 and infection post-liver transplantation. 11 Of note, MBL is an example of a pattern recognition molecule that plays a dual role in modifying inflammatory responses to sterile and infectious injury. In the context of sterile inflammatory diseases such as myocardial and gastrointestinal ischemic reperfusion injury, MBL and the lectin pathway mediate the development of disease through complement-mediated regulation of proinflammatory cytokines and inflammation, leading to exacerbated pathology and tissue injury. 12 However, the immunoregulatory role of MBL in sterile liver inflammation, especially the function of the innate immune response, has not yet been thoroughly investigated.
The administration of carbon tetrachloride (CCl 4 ) has become one of the most commonly used experimental models for inducing toxin-mediated liver injury. This type of acute liver injury is characterized by the elevated serum level of alanine transaminase (ALT) and typical centrilobular necrosis. 13 Of note, the subsequent activation of hepatic macrophages, along with increased production of inflammatory cytokines and chemokines, is also a contributing factor to the development of CCl 4 -induced acute liver injury. 14 In this study, we used MBL-deficient (MBL −/− ) mice to explore the potential effect of MBL on the CCl 4 -induced acute liver injury. The results showed that MBL −/− mice were susceptible to CCl 4 -induced liver injury, which attributed to the increased hepatic neutrophil recruitment. Indeed, MBL limited the expression of inflammatory chemokine CXCL2 from hepatic macrophage, which is responsible for neutrophil migration during liver injury. Furthermore, we provided the evidence that restoration of hepatic MBL expression in MBL −/− mice attenuated the liver damage caused by CCl 4 administration. In summary, our findings revealed an essential mechanism of hepatic MBLmediated protection of sterile liver injury, which provides insight into liver pathophysiology in patients with MBL deficiency and offers new opportunities to develop future therapeutic strategies for such liver diseases.
MATERIAL AND METHODS

Mice and reagents
MBL-deficient (MBL -/-) mice were obtained from the Jackson Laboratory (Bar Harbor, ME, USA). C57BL/6 mice were purchased from the Animal Institute of Southern Medical University (Guangzhou, China).
Mice were maintained under specific pathogen-free conditions. All animal experiments in this study were approved by the Welfare and Ethical Committee for Experimental Animal Care of Southern Medical University. 
Model of sterile liver injury
Acute liver injury was induced by a single intraperitoneal injection of CCl 4 . CCl 4 was diluted in olive oil to 1:3 and injected into mice at a dose of 1 l/g body weight. For CXCL2 neutralization in vivo, mice were intravenously injected with 10 g of anti-CXCL2 antibody (R&D Systems) before CCl 4 treatment. To deplete liver macrophages, mice were intravenously injected with 200 l of clodronate-containing liposomes (FormuMax Scientific). Alternatively, neutrophil depletion was achieved by injecting 100 g of anti-mouse Ly6G (RB6-8C5; Invitrogen). To restore hepatic MBL expression, the adeno-associated virus (AAV) vector expressing mouse MBL2 under the control of the liver-specific thyroid hormone-binding globulin (Tbg) promoter was generated by Obio Technology (Shanghai, China). AAV-TBG-GFP (pAAV-control) or AAV-TBG-MBL2-GFP (pAAV-MBL2) (1 × 10 10 genome copies/mouse) was delivered by tail vein injection 3 weeks before CCl4 administration.
Histologic and immunohistochemical staining
Paraffin-embedded liver tissue blocks were cut into 5 m slices and mounted onto polylysine-charged glass slides. Tissue injury was evaluated by H&E staining. Cell death was measured by TUNEL staining (Beyotime Biotechnology, Shanghai, China) according to the manufacturer's instruction. Antigen retrieval was performed in a citrate buffer (pH 6.0) at 100 • C for 10 min, and endogenous peroxidase activity was blocked by exposure to 3% H 2 O 2 for 15 min. Sections were then incubated with primary antibodies at 4 • C overnight.
Immuno-reactivity was detected using the corresponding HRPconjugated secondary antibody and visualized using diaminobenzidine kit (Beyotime Biotechnology).
Measurement of serum ALT, lactate dehydrogenase, and inflammatory cytokines
Individual mouse serum was collected at different time points after CCl 4 injection. Serum alanine aminotransferase (ALT) and lactate dehydrogenase (LDH) activities were measured with commercial kits (Jiancheng Biotech, Nanjing, China), according to the manufacturer's instructions. Cytokine levels in the sera were assessed using commercial ELISA kits purchased from eBioscience (San Diego, CA, USA).
Isolation of hepatic nonparenchymal cells
Isolation of hepatic nonparenchymal cells (NPCs) was performed by following method established previously with slight modifications. 15 In brief, mice were anesthetized, and livers were perfused slowly via the inferior vena cava with 30 ml of warm PBS at a rate of 5 ml/min, and then digested with 20 ml of liver digest medium (RPMI-1640, Collagenase IV at 0.5 mg/ml, DNAse Ӏ at 0.1 mg/ml) at a rate of 5 ml/min.
TA B L E 1 Primers for the inflammatory cytokines and chemokines
After the gallbladder was removed, the livers were carefully excised and passed through a 70 m cell strainer. The single cell suspension was centrifuged at 50 g for 2 min at 4 • C to remove hepatocytes. NPCs were purified using centrifugation at 1000 g for 25 min in a 30% percoll gradient, then the cells were washed twice with PBS and subsequent resuspended for further analysis.
Immunofluorescence
The liver NPCs were plated on a glass coverslip in a 6-well plate. After 
Flow cytometry
Isolation of RNA and quantitative real-time PCR
Mouse liver total RNA or cells RNA was extracted using TRIzol reagent (TransGene Biotech, Beijing, China) and then transcribed into cDNA using TranScript All-in-One First-Strand cDNA Synthesis SuperMix (TransGene Biotech), as instructed by the manufacturer.
Real-time PCR was performed with an Eppendorf Realplex PCR system using TransStart Tip Green qPCR SuperMix (TransGene Biotech).
The expression was normalized to the expression of the housekeeping gene GAPDH. The primer sequences used in the experiment are shown in Table 1 .
Western blotting analysis
Protein lysates prepared using RIPA buffer (50 mM Tris, 150 mM NaCl, and 1% Nonidet P-40, pH 7. 
Statistical analysis
All values were expressed as mean ± SEM. One-way ANOVA was used for comparisons among multiple groups. Differences between two groups within experiments were analyzed by Student's t-test. Value of P < 0.05 was considered statistically significant.
RESULTS
Mice deficient in MBL are highly susceptible to CCl 4 -induced sterile liver injury
To investigate the role of MBL in sterile liver injury, sex and agematched C57BL/6 WT and MBL -/-mice were received a single dose of CCl 4 (1 l/g body weight), followed by serum analysis of ALT and LDH as well as liver pathologic changes. Serum collected from MBL -/-mice showed significantly increased levels of ALT activity and LDH activity compared with that from WT mice after CCl 4 injection ( Fig. 1A and B). CCl 4 -treated MBL -/-mice displayed much more hepatocyte death and disseminated hemorrhage than WT counterparts (Fig. 1C) .
Besides, more TUNEL positive cells were found in the livers of CCl 4 -treated MBL -/-mice than those from WT controls (Fig. 1D) . Next, 
MBL deficiency enhances liver recruitment of neutrophils during CCl 4 -induced liver injury
Similar to microbial-induced inflammation, sterile inflammation is marked by the recruited neutrophils and activated macrophages, which continue to secrete inflammatory cytokines and chemokines.
To determine whether neutrophils or macrophages infiltrated the liver in response to hepatocyte death, we used flow cytometry to assess the population of neutrophils and liver macrophages, characterized as CD11b + F4/80 + cells, 16 presented in the liver in control mice and at 6, 12, and 24 h after injection of CCl 4 . As shown, CCl 4 -treated MBL -/-mice displayed a marked increase in the frequency of neutrophils in the livers compared with WT counterparts (Fig. 2A) . In contrast, the percentage of liver-infiltrating macrophages was comparable between WT and MBL -/-mice after CCl 4 administration (Fig. 2B) . Analysis of Ly6C expression on this subset identified two distinct hepatic recruited macrophage populations: Ly6C hi and Ly6C lo (Fig. 2C ). There was a significant increase in the Ly6C hi population (inflammatory macrophages), 17 not Ly6C lo macrophage, in both WT and MBL -/-mice during the CCl 4 challenge. However, the frequency of these two subsets was similar between CCl 4 -treated WT and MBL -/-mice (Fig. 2C) . Furthermore, the immunohistochemical staining analysis confirmed that increased neutrophils, but not macrophages, infiltrated into the liver in MBL -/-mice compared with that in WT mice upon CCl 4 challenge ( Fig. 2D and E) . These results suggested that MBL deficiency promoted neutrophil recruitment to liver during CCl 4 -induced liver damage. MBL -/-mice after neutrophil depletion (Fig. 3A) . Besides, serum ALT activity ( Fig. 3B ) and LDH activity (Fig. 3C) were comparable between 
Neutrophil is
CXCL2 is responsible for hepatic neutrophil recruitment during CCl 4 -induced liver injury
Previous studies have reported that the CXCL1 and CXCL2 are potent chemotactic and activation factors of neutrophils and play a critical role in neutrophil recruitment during acute liver injury. 18, 19 The hepatic CXCL1 expression is comparable between CCl 4 -administrated WT and MBL -/-mice, however, the expression of CXCL2 was strongly elevated in MBL -/-mice compared with those in WT mice upon (Fig. 4C ) and immunohistochemical staining (Fig. 4D) . In addition, the severity of liver damage was reduced and comparable between CCl 4 -treated WT and MBL -/-mice with CXCL2 (Fig. 4E) . The sera collected from CCl 4 -administrated WT and MBL -/-mice showed no significant difference in the levels of ALT activity and LDH activity after anti-CXCL2 treatment (Fig. 4F ).
These data suggested that MBL deficiency aggravated the pathogenesis of CCl 4 -induced liver injury by promoting the hepatic expression of CXCL2 towards neutrophil infiltration.
MBL regulates the CXCL2 expression in hepatic macrophages
It has been reported that CXCL2 is produced mainly by liver macrophages. 18 We, therefore, measured the CXCL2 production in hepatic macrophages from WT and MBL -/-mice upon CCl 4 administration. As expected, CXCL2 expression production was significantly increased in macrophages from the liver of MBL -/-mice compared with those of WT mice after CCl 4 treatment at both mRNA and protein levels ( Fig. 5A and B) . The result was also confirmed by an independent immunofluorescence staining ( (Fig. 5D) . Meanwhile, the infiltration of neutrophils was decreased and comparable between CCl 4 -treated WT and MBL -/-mice when macrophages were depleted in vivo ( Fig. 5E and F) . These data suggested MBL regulates neutrophil infiltration via modulating the expression of CXCL2 from hepatic macrophages.
Restoration of hepatic MBL expression in MBL deficient mice attenuated the CCl4-induced liver injury
Generally, rodent MBL is the product of two separate genes encoding serum MBL-A (MBL1) and liver MBL-C (MBL2). 20 Immunohistochemical staining showed that the level of MBL2 expression in the liver was highly elevated in mice after CCl4 injection (Fig. 6A ), indicated that MBL2 might be more important than MBL1 in the pathogenesis of CCl4-induced liver injury.
To determine whether restoration of hepatic MBL2 expression could protect MBL -/-mice against CCl4-induced liver injury, we generated an MBL2-expressing AAV. Tail vein injection of pAAV-MBL2 into MBL -/-mice restored MBL2 expression in liver ( Fig. 6B and C) . We next examined the liver damage in WT and MBL -/-mice which were treated with control AAV (pAAV-con) or pAAV-MBL2 before CCl4 injection.
As shown, MBL -/-mice after pAAV-con pretreatment developed more liver damage than WT mice upon CCl 4 challenge (Fig. 6D) . However, pAAV-MBL2 delivery nearly completely eliminated the aggravated liver damage in the absence of MBL, indicated by comparable liver damage in WT and MBL -/-mice with liver-specific MBL2 overexpression (Fig. 6D) . Serum ALT activity and LDH activity were greatly attenuated after pAAV-MBL2 pretreatment in MBL -/-mice (Fig. 6E) .
Notably, pAAV-MBL2 pretreatment decreased the hepatic expression of CXCL2 in MBL -/-mice, reaching a similar level to that in WT mice (Fig. 6F ). In addition, FACS analysis (Fig. 6G ) and immunohistochemical staining (Fig. 6H) showed that the percentage of neutrophils in MBL -/-mice also returned to the levels seen in WT mice following administration of pAAV-MBL2. Together, the results indicated that hepatic MBL expression could limit the expression of chemokines from hepatic macrophages and inhibit the subsequent neutrophils recruitment, thereby suppressing the sterile liver inflammation.
DISCUSSION
MBL is a liver-derived protein and is secreted into the serum, which is able to modulate inflammation during infection and tissue injury. 6, 7 In this study, we demonstrated that MBL deficiency exacerbates Hepatocyte death is a central mechanism involved in both pathogen-and sterile injury-induced pathologies and contributes to the development of liver disease. 21 The efficient clearance of dead cells is a critical liver function to maintain tissue homeostasis.
Defects in apoptotic cell clearance have been linked with the increased production of pro-inflammatory mediators and exacerbated liver inflammation. 22 34 In liver injury, activated hepatic macrophages are the primary source of CXCL2. 19 As known, hepatic macrophages are a remarkably heterogeneous population of immune cells that fulfill diverse functions in homeostasis, disease progression, and regression from injury. 16 The diverse features of macrophages include clearance of pathogens or cellular debris as well as initiating and resolving inflammation in response to injury. Although more work is needed to further determine the exact molecular mechanisms controlled by MBL in function of liver macrophage, our results convincingly demonstrated that macrophage displayed more inflammatory phenotypic characteristics in MBL deficiency mice than WT mice in the context of sterile liver inflammation. Indeed, MBL directly interacts with several cell surface pattern recognition receptors (e.g., TLRs, MD2, and CD14) and has been shown to alter the function and cytokine production of monocytes, macrophages, and dendritic cells. 20, 28, 36 A number of studies demonstrated that MBL inhibits the production of pro-inflammatory cytokines by macrophages during innate immune response. [36] [37] [38] [39] [40] In contrast, Ciencewicki et al. 41 reported that the number of neutrophils and the level of CXCL2 in the bronchoalveolar lavage fluid were significantly higher in WT mice than MBL −/− mice in response to ozone-induced lung damage. Therefore, the role of MBL in regulating inflammatory events may vary depending on the cause of injury and the tissue involved.
Since that liver is the pivotal source of MBL which is mainly produced by hepatocytes, 6 we have generated an MBL expression vector using AAV type 8 under the control of the liver-specific Tbg promoter as previously described 42 
